Vaxdyn

GlycoVaxyn

This biotechnology company develops bioconjugate vaccines for pharmaceutical partners to prevent and treat bacterial infections.

Affinivax

This biopharmaceutical company develops vaccines against infectious diseases and hospital-associated infections for healthcare providers and public health organisations worldwide.

ArkVax

ArkVax develops low-cost recombinant glycoconjugate vaccines for the livestock industry to protect animals from bacterial diseases and combat antimicrobial resistance.

Calixa Therapeutics

This biopharmaceutical company develops novel antibiotics to treat serious infections caused by multi-drug-resistant pathogens for hospital patients.

Adjutecpharma

This company develops antibiotic resistance breakers for healthcare providers to treat patients with life-threatening bacterial infections.

Phaxiam

The company develops bacteriophage-based treatments to combat antibiotic-resistant bacterial infections for patients with severe hospital-acquired or chronic respiratory conditions.

Nykode Therapeutics

This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.

Centivax

This company develops broad-spectrum vaccines and monoclonal antibodies using computational immune engineering to protect against infectious diseases and pathogens for global healthcare systems.